Selective blockade of NF‐κB by novel mutated IκBα suppresses CD3/CD28‐induced activation of memory CD4+ T cells in asthma
Authors:
- M.‐S. ZhangMZM.‐S. Zhang
- A.‐H. HuAHA.‐H. Hu
- Z. ZhuZZZ. Zhu
- K.‐S. YinKYK.‐S. Yin
Abstract
Background: Nuclear factor κB (NF‐κB) overactivation plays a crucial role in T‐helper 2 (Th2)‐biased allergic airway inflammation by increased activation and decreased apoptosis of CD4+ T cells. We have shown that targeted NF‐κB suppression in dendritic cells by adenoviral gene transfer of a novel mutated inhibitor of NF‐κB (IκBα) (AdIκBαM) contributes to T‐cell tolerance, but the immunosuppressive action of AdIκBαM on memory (CD45RO+) CD4+ T cells remains enigmatic.Methods: CD45RO+ T cells from Dermatophagoides farinaei‐sensitized asthmatic patients, untransfected or transfected with AdIκBαM or AdLacZ (β‐galactosidase) for 24 h, were stimulated with anti‐CD3 (1.0 μg/ml) plus anti‐CD28 (0.5 μg/ml) monoclonal antibody for an additional 24 h. IκBαM transgene expression and NF‐κB activation were detected by polymerase chain reaction (PCR), reverse transcription‐PCR (RT‐PCR), Western blot analysis, and electrophoretic mobility shift assay. Phenotype and apoptosis were measured by flow cytometry, annexin V binding, and terminal deoxyribonucleotidyl transferase‐mediated dUTP nick end labeling analyses. Cytokine production and cell proliferation were determined using enzyme‐linked immunosorbent assay and [3H] thymidine incorporation.Results: A unique 801‐bp IκBαM cDNA and a dose‐dependent increase in IκBαM transgene expression were observed in AdIκBαM‐transfected CD45RO+ T cells. Significantly, AdIκBαM inhibited CD3/CD28‐mediated NF‐κB activation in CD45RO+ T cells, leading to evident apoptosis, reduction of eotaxin, RANTES, Th1 [interferon (IFN)‐γ and interleukin (IL)‐2], and Th2 (IL‐4, IL‐5, and IL‐13 despite a slight decrease in IL‐10) cytokines and secondary proliferative response. AdIκBαM also upregulated cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4) and downregulated CD69 besides no change in CD28.Conclusion: IκBαM might be beneficial to augment memory CD4+ T‐cell tolerance through modulating B7‐CD28/CTLA‐4 co‐stimulatory pathways and NF‐κB‐dependent cytokine profiles in allergic inflammatory diseases including asthma.Keywords
This publication has 33 references indexed in Scilit:
- TNF-α induced CD38 expression in human airway smooth muscle cells: role of MAP kinases and transcription factors NF-κB and AP-1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunitNature Immunology, 2007
- Leukocyte-Derived IL-10 Reduces Subepithelial Fibrosis Associated with Chronically Inhaled EndotoxinAmerican Journal of Respiratory Cell and Molecular Biology, 2006
- Effects of adenoviral gene transfer of mutated IkappaBalpha, a novel inhibitor of NF-kappaB, on human monocyte-derived dendritic cells1Acta Pharmacologica Sinica, 2006
- Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretionAllergy, 2006
- Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell FunctionScience, 2005
- Selective inhibition of NF‐κB in dendritic cells by the NEMO‐binding domain peptide blocks maturation and prevents T cell proliferation and polarizationEuropean Journal of Immunology, 2005
- Inhibition of NF-κB by a cell permeable form of IκBα induces apoptosis in eosinophilsBiochemical and Biophysical Research Communications, 2004
- CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigmJournal of Allergy and Clinical Immunology, 2004
- The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune ResponsesAnnual Review of Immunology, 2002